U.S. President Donald Trump’s administration entered into an agreement with American biotech company Moderna for 100 million doses of its experimental coronavirus vaccine, the White House and the drugmaker announced on Tuesday.
U.S. President Donald Trump’s administration entered into an agreement with American biotech company Moderna for 100 million doses of its experimental coronavirus vaccine, the White House and the drugmaker announced on Tuesday.